331 related articles for article (PubMed ID: 17174914)
21. Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness.
Gaspar NJ; Li L; Kapoun AM; Medicherla S; Reddy M; Li G; O'Young G; Quon D; Henson M; Damm DL; Muiru GT; Murphy A; Higgins LS; Chakravarty S; Wong DH
Mol Pharmacol; 2007 Jul; 72(1):152-61. PubMed ID: 17400764
[TBL] [Abstract][Full Text] [Related]
22. Ral GTPase-activating protein regulates the malignancy of pancreatic ductal adenocarcinoma.
Yoshimachi S; Shirakawa R; Cao M; Trinh DA; Gao P; Sakata N; Miyazaki K; Goto K; Miura T; Ariake K; Maeda S; Masuda K; Ishida M; Ohtsuka H; Unno M; Horiuchi H
Cancer Sci; 2021 Aug; 112(8):3064-3073. PubMed ID: 34009715
[TBL] [Abstract][Full Text] [Related]
23. RalA and RalB: antagonistic relatives in cancer cell migration.
Oxford G; Owens CR; Titus BJ; Foreman TL; Herlevsen MC; Smith SC; Theodorescu D
Cancer Res; 2005 Aug; 65(16):7111-20. PubMed ID: 16103060
[TBL] [Abstract][Full Text] [Related]
24. Ral GTPase down-regulation stabilizes and reactivates p53 to inhibit malignant transformation.
Tecleab A; Zhang X; Sebti SM
J Biol Chem; 2014 Nov; 289(45):31296-309. PubMed ID: 25210032
[TBL] [Abstract][Full Text] [Related]
25. Expression of ral GTPases, their effectors, and activators in human bladder cancer.
Smith SC; Oxford G; Baras AS; Owens C; Havaleshko D; Brautigan DL; Safo MK; Theodorescu D
Clin Cancer Res; 2007 Jul; 13(13):3803-13. PubMed ID: 17606711
[TBL] [Abstract][Full Text] [Related]
26. Geranylgeranyltransferase I inhibitors target RalB to inhibit anchorage-dependent growth and induce apoptosis and RalA to inhibit anchorage-independent growth.
Falsetti SC; Wang DA; Peng H; Carrico D; Cox AD; Der CJ; Hamilton AD; Sebti SM
Mol Cell Biol; 2007 Nov; 27(22):8003-14. PubMed ID: 17875936
[TBL] [Abstract][Full Text] [Related]
27. [Signaling pathways regulating the expression of proteases during tumor progression].
de Kier Joffé EB; Mazzoni E; Aguirre Ghiso JA
Medicina (B Aires); 2000; 60 Suppl 2():34-40. PubMed ID: 11188928
[TBL] [Abstract][Full Text] [Related]
28. RalA but not RalB enhances polarized delivery of membrane proteins to the basolateral surface of epithelial cells.
Shipitsin M; Feig LA
Mol Cell Biol; 2004 Jul; 24(13):5746-56. PubMed ID: 15199131
[TBL] [Abstract][Full Text] [Related]
29. Ral-GTPase interacts with the beta1 subunit of Na+/K+-ATPase and is activated upon inhibition of the Na+/K+ pump.
Bhullar RP; Clough RR; Kanungo J; Elsaraj SM; Grujic O
Can J Physiol Pharmacol; 2007; 85(3-4):444-54. PubMed ID: 17612654
[TBL] [Abstract][Full Text] [Related]
30. The RAL Enigma: Distinct Roles of RALA and RALB in Cancer.
Richardson DS; Spehar JM; Han DT; Chakravarthy PA; Sizemore ST
Cells; 2022 May; 11(10):. PubMed ID: 35626682
[TBL] [Abstract][Full Text] [Related]
31. Ral GTPase Activation by Downregulation of RalGAP Enhances Oral Squamous Cell Carcinoma Progression.
Gao P; Liu S; Yoshida R; Shi CY; Yoshimachi S; Sakata N; Goto K; Kimura T; Shirakawa R; Nakayama H; Sakata J; Kawashiri S; Kato K; Wang XY; Horiuchi H
J Dent Res; 2019 Aug; 98(9):1011-1019. PubMed ID: 31329042
[TBL] [Abstract][Full Text] [Related]
32. Different metastasis promotive potency of small G-proteins RalA and RalB in in vivo hamster tumor model.
Rybko VA; Knizhnik AV; Komelkov AV; Aushev VN; Trukhanova LS; Tchevkina EM
Cancer Cell Int; 2011 Jun; 11(1):22. PubMed ID: 21714887
[TBL] [Abstract][Full Text] [Related]
33. Ral GTPases regulate cell-mediated cytotoxicity in NK cells.
Sánchez-Ruiz J; Mejías R; García-Belando M; Barber DF; González-García A
J Immunol; 2011 Sep; 187(5):2433-41. PubMed ID: 21810610
[TBL] [Abstract][Full Text] [Related]
34. A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis.
Fujisawa T; Joshi B; Nakajima A; Puri RK
Cancer Res; 2009 Nov; 69(22):8678-85. PubMed ID: 19887609
[TBL] [Abstract][Full Text] [Related]
35. Characterization of RalB-Sec5-TBK1 function in human oncogenesis.
Chien Y; White MA
Methods Enzymol; 2008; 438():321-9. PubMed ID: 18413258
[TBL] [Abstract][Full Text] [Related]
36. Opposing roles of netrin-1 and the dependence receptor DCC in cancer cell invasion, tumor growth and metastasis.
Rodrigues S; De Wever O; Bruyneel E; Rooney RJ; Gespach C
Oncogene; 2007 Aug; 26(38):5615-25. PubMed ID: 17334389
[TBL] [Abstract][Full Text] [Related]
37. Dual role of Ski in pancreatic cancer cells: tumor-promoting versus metastasis-suppressive function.
Wang P; Chen Z; Meng ZQ; Fan J; Luo JM; Liang W; Lin JH; Zhou ZH; Chen H; Wang K; Shen YH; Xu ZD; Liu LM
Carcinogenesis; 2009 Sep; 30(9):1497-506. PubMed ID: 19546161
[TBL] [Abstract][Full Text] [Related]
38. Adrenomedullin is expressed in pancreatic cancer and stimulates cell proliferation and invasion in an autocrine manner via the adrenomedullin receptor, ADMR.
Ramachandran V; Arumugam T; Hwang RF; Greenson JK; Simeone DM; Logsdon CD
Cancer Res; 2007 Mar; 67(6):2666-75. PubMed ID: 17363587
[TBL] [Abstract][Full Text] [Related]
39. Activation and involvement of Ral GTPases in colorectal cancer.
Martin TD; Samuel JC; Routh ED; Der CJ; Yeh JJ
Cancer Res; 2011 Jan; 71(1):206-15. PubMed ID: 21199803
[TBL] [Abstract][Full Text] [Related]
40. Solution structure and dynamics of the small GTPase RalB in its active conformation: significance for effector protein binding.
Fenwick RB; Prasannan S; Campbell LJ; Nietlispach D; Evetts KA; Camonis J; Mott HR; Owen D
Biochemistry; 2009 Mar; 48(10):2192-206. PubMed ID: 19166349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
